101 related articles for article (PubMed ID: 28276170)
1. Pre-treatment serum lactate dehydrogenase as a biomarker in small cell lung cancer.
Hsieh AH; Tahkar H; Koczwara B; Kichenadasse G; Beckmann K; Karapetis C; Sukumaran S
Asia Pac J Clin Oncol; 2018 Apr; 14(2):e64-e70. PubMed ID: 28276170
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of potential usefulness of serum lactate dehydrogenase level in follow-up of small cell lung cancer.
Chen C; Zhu YH; Huang JA
J Cancer Res Ther; 2018 Jun; 14(Supplement):S336-S340. PubMed ID: 29970686
[TBL] [Abstract][Full Text] [Related]
3. The value of prognostic factors in Chinese patients with small cell lung cancer: A retrospective study of 999 patients.
Hong X; Xu Q; Yang Z; Wang M; Yang F; Gao Y; Zhou F; Wang L; Liu B; Chen G
Clin Respir J; 2018 Feb; 12(2):433-447. PubMed ID: 27460525
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM
Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy.
Liu X; Zhang W; Yin W; Xiao Y; Zhou C; Hu Y; Geng S
Medicine (Baltimore); 2017 Nov; 96(46):e8258. PubMed ID: 29145241
[TBL] [Abstract][Full Text] [Related]
6. Serum lactate dehydrogenase levels at presentation predict outcome of patients with limited-stage small-cell lung cancer.
Tas F; Aydiner A; Demir C; Topuz E
Am J Clin Oncol; 2001 Aug; 24(4):376-8. PubMed ID: 11474266
[TBL] [Abstract][Full Text] [Related]
7. Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes.
Lee DS; Park KR; Kim SJ; Chung MJ; Lee YH; Chang JH; Kang JH; Hong SH; Kim MS; Kim YS
Tumour Biol; 2016 Jan; 37(1):619-25. PubMed ID: 26240025
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic value of pretreatment serum LDH in patients with limited disease small-cell lung carcinoma.
Stokkel MP; Van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
Int J Biol Markers; 1997; 12(4):162-7. PubMed ID: 9582606
[TBL] [Abstract][Full Text] [Related]
9. Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer - a retrospective single institution analysis.
Hermes A; Gatzemeier U; Waschki B; Reck M
Respir Med; 2010 Dec; 104(12):1937-42. PubMed ID: 20719490
[TBL] [Abstract][Full Text] [Related]
10. Increased serum carcinoembryonic antigen level can predict poor survival of patients with small cell lung cancer.
Zhu H; Guo H; Li M; Zhang Y; Han A; Shi F; Kong L; Yu J
Transl Res; 2015 Oct; 166(4):355-65. PubMed ID: 25936590
[TBL] [Abstract][Full Text] [Related]
11. Serum Heat Shock Protein 70, as a Potential Biomarker for Small Cell Lung Cancer.
Balázs M; Zsolt H; László G; Gabriella G; Lilla T; Gyula O; Balázs D; Éva M; Zoltán B; Zoltán P; Judit K
Pathol Oncol Res; 2017 Apr; 23(2):377-383. PubMed ID: 27704355
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer.
Sagman U; Feld R; Evans WK; Warr D; Shepherd FA; Payne D; Pringle J; Yeoh J; DeBoer G; Malkin A
J Clin Oncol; 1991 Jun; 9(6):954-61. PubMed ID: 1851821
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancer.
Chang MH; Lee J; Han J; Park YH; Ahn JS; Park K; Ahn MJ
APMIS; 2009 Dec; 117(12):861-9. PubMed ID: 20078550
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of standardised uptake value (SUV
Yilmaz Demirci N; Yilmaz Ü; Biner Uslu I; Dikmen A; Yılmaz A; Erdoğan Y
Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 26988938
[TBL] [Abstract][Full Text] [Related]
15. The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients.
Hong S; Zhou T; Fang W; Xue C; Hu Z; Qin T; Tang Y; Chen Y; Ma Y; Yang Y; Hou X; Huang Y; Zhao H; Zhao Y; Zhang L
Tumour Biol; 2015 May; 36(5):3389-97. PubMed ID: 25527156
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of cachexia score assessed by CT in male patients with small cell lung cancer.
Kim EY; Lee HY; Kim YS; Park I; Ahn HK; Cho EK; Jeong YM; Kim JH
Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28426181
[TBL] [Abstract][Full Text] [Related]
17. Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer?
Hirose T; Okuda K; Yamaoka T; Ishida K; Kusumoto S; Sugiyama T; Shirai T; Ohnshi T; Ohmori T; Adachi M
Lung Cancer; 2011 Feb; 71(2):224-8. PubMed ID: 20537424
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment serum lactate dehydrogenase as additional staging parameter in patients with small-cell lung carcinoma.
Stokkel MP; van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
J Cancer Res Clin Oncol; 1998; 124(3-4):215-9. PubMed ID: 9619749
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of lactate dehydrogenase B according to histologic type of non-small-cell lung cancer and its association with serum lactate dehydrogenase.
Koh YW; Lee SJ; Park SY
Pathol Res Pract; 2017 Sep; 213(9):1134-1138. PubMed ID: 28756978
[TBL] [Abstract][Full Text] [Related]
20. Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
van Zandwijk N; Jassem E; Bonfrer JM; Mooi WJ; van Tinteren H
Semin Oncol; 1992 Feb; 19(1 Suppl 2):37-43. PubMed ID: 1329221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
